Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II): Randomized Clinical Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03290625

Organisation Name: Universidade Federal de Goias

Overal Status: Completed

Start Date: November 9, 2017

Last Update: June 30, 2020

Lead Sponsor: Universidade Federal de Goias

Brief Summary: Parallel clinical trial focusing on procedural pediatric sedation in the dental setting. Children will be randomized to treatment according to a predetermined sequence of interventions consisting of: 1. intranasal sedation with ketamine-associated dexmedetomidine (Experimental Group), 2. intranasal sedation with dexmedetomidine as sole drug (Control Group). Primary outcome is children's behavior during the dental treatment. Secondary outcomes are: children's pain, memory and stress (salivary cortisol and melatonin); perception of the accompanying adult, dentist and child about dental sedation; cost-effectiveness of this type of sedation; psychosocial variables; children's quality of life.

Conditions:
  • Caries of Infancy
  • Dental Anxiety


Total execution time in seconds: 0.15459704399109